MKI67 and glioma: Further research revealed that after parthenolide treatment, in addition to a significant decrease in overall cell viability, the Ki-67 positivity rates of surviving cells also decreased significantly, indicating that the induction of differentiation by parthenolide attenuated the proliferative capacity of glioma cells.